Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Effect of Buspirone on Esophageal Sensitivity in Healthy Volunteers
2011-005059-15Phase 4Completed
- Sponsor
- UZ Leuven
- Start
- Oct 2011
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial in gastroesophageal reflux disease (GERD) and esophageal hypersensitivity comparing Buspirone with Placebo (2 arms). Primary endpoint: Esophageal sensitivity VAS comparison. Started Oct 2011; status: completed.
02
Drugs
buspirone
03
Conditions
gastroesophageal reflux disease (GERD)esophageal hypersensitivity
Beyond the preview
Go deeper on 2011-005059-15.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2011-005059-15.